glp-1 compounding fda is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA Moves to Restrict Mass-Marketed

For many patients, this pivot may not be as simple as the company suggests and it may hit them harder in their wallets

That means craftsmanship and storytelling matter more than ever

For eligible Medicaid users, AirTalk Wireless offers provider-supported service plans that may include: A discounted or free smartphone, depending on availability and promotion Monthly talk, text, and data with no contracts Nationwide coverage to stay reachable during reviews and follow-ups By enrolling through AirTalk Wireless, Medicaid patients can respond to prescription updates, coordinate with providers, and avoid unnecessary delays during medication approval

Regular check-ups are key during this time

Prior authorization requirements for specific drugs, including GLP-1 agents and biologics, differ by state program and by managed Medicaid plan